Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Liquid Phase Fragment Condensation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103694336A details a novel solid-liquid phase fragment condensation method for Thymosin alpha 1, offering >99% purity and scalable production for reliable supply chains.
Patent CN103665144B reveals high-yield liquid-phase fragment condensation for Thymosin alpha 1, offering superior purity and scalable manufacturing for global supply chains.
Patent CN101475631B reveals a scalable liquid-phase route for Bivalirudin, offering significant cost reduction in API manufacturing and eliminating toxic HF cleavage steps.
Patent CN112521482A reveals a solid-liquid combined method for nesiritide. Achieve high purity and cost reduction in pharmaceutical intermediates manufacturing with scalable routes.